In this report, we demonstrate that inhibition of Bcl-xL causes synthetic lethality in IDH1-mutated glioblastoma cells in vitro and in vivo and that these effects are mediated by the oncometabolite, 2-HG, which reduces Mcl-1 protein levels. Here, MCL1 is linked to glioblastoma.